Chemotherapy is the standard of care for locally advanced pancreatic cancer. There are two standard regimens, Gem/A and FolfirinOX. These regimens are modestly better then gemcitabine alone, but there is a clear barrier in median survival of 12 months. This will probably never be surpassed with chem...